Alcon, the global leader in eye care and a division of Novartis, has achieved European CE Mark for the Clareon IOL with the AutonoMe delivery system.  AutonoMe is the first-and-only automated, disposable, pre-loaded IOL delivery system that enables precise delivery of the IOL into the capsular bag in patients undergoing cataract surgery. The new device is being introduced with the Clareon IOL, a new BioMaterial with an advanced design that enables sharp, crisp vision; low edge glare; and, unsurpassed optic clarity. These new innovations, along with supporting scientific data, will be presented at the XXXV congress of the European Society of Cataract & Refractive Surgeons (ESCRS) taking place October 7 - 11 in Lisbon, Portugal.

"With the introduction of Clareon AutonoMe(TM), we are proud to unveil our latest innovations to benefit doctors and their patients undergoing cataract surgery," said Mike Ball, chief executive officer, Alcon. "Throughout Alcon's history, we have worked with doctors to enhance and transform the way cataract surgery is performed. Clareon AutonoMe builds upon the comprehensive legacy of AcrySof by offering cataract surgeons easy, intuitive control of IOL delivery with the newest optic material."

The AutonoMe delivery system, preloaded with the Clareon IOL, is designed with advancements intended to benefit both surgeons and cataract patients. Its automated CO2-powered delivery mechanism and intuitive, ergonomic design allow precise and simplified single-handed control of IOL placement during cataract surgery.

"Comfort and efficiency during the cataract surgery are key to achieving better outcomes. This new device is expected to improve the procedure and ultimately to reduce surgical time," said Prof. Rudolph Nuijts, University of Maastricht, Netherlands. "This is great news for surgeons because Clareon AutonoMe provides a cutting-edge, intuitive and easy-to-use device that allows precise and controlled IOL delivery."

The Clareon hydrophobic acrylic IOL, which received CE Mark in May, is made of a patented, innovative optic polymer material. Clareon builds on and maintains the benefits of the proven AcrySof platform with a new optic BioMaterial that offers cataract patients unsurpassed clarity.